Wound Infiltration and Breast Cancer Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Breast Cancer
Interventions
PROCEDURE

infiltration with ropivacaine solution

Patients are allocated randomly into two arms on the morning of surgery, using random numbers and sealed envelopes. In the treated group infiltration is performed with a ropivacaine 7.5 mg.ml-1 solution and in the control group with an isotonic saline solution. In the two groups patients are operated under and nitrous oxide for maintenance. Dexamethasone 4 mg was given intravenously after anaesthetic induction for prevention of postoperative nausea and vomiting. Twenty milliliters of the allocated solution were used at the end of the surgical procedure to infiltrate the subcutaneous and deep layers at the level of the breast and axilla surgical incision.

Trial Locations (1)

75020

Hopital Tenon, Paris

All Listed Sponsors
lead

Tenon Hospital, Paris

OTHER

NCT01404377 - Wound Infiltration and Breast Cancer Surgery | Biotech Hunter | Biotech Hunter